Ingested (oral) ACTH inhibits EAE (Q82472688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

16 January 2020

title

Ingested (oral) ACTH inhibits EAE (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Staley A. Brod

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21081248

27 August 2024

Zachary M. Hood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21081248

27 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21081248

27 August 2024

publication date

16 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

full work available at URL

16 January 2020

https://api.elsevier.com/content/article/PII:S0165572810004807?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

https://api.elsevier.com/content/article/PII:S0165572810004807?httpAccept=text/plain

27 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Journal of Neuroimmunology

27 August 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

16 January 2020

volume

232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

16 January 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

131-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

16 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25 Foxp3 regulatory T cells

27 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons

27 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokines

27 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Ingested (oral) SIRS peptide 1-21 suppresses type 1 diabetes in NOD mice

27 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Ingested (oral) alpha-MSH inhibits acute EAE

27 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis

27 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis

27 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion

27 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Ingested interferon alpha induces Mx mRNA

27 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications

27 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences

27 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.

27 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis

27 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

27 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

The brain is an important target of adrenal steroid actions. A comparison of synthetic and natural steroids

27 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

27 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes

27 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Effect of Macrophage Colony-Stimulating Factor (M-CSF) on Mouse Immune Responses in Vivo

27 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions

27 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Molecular cloning of the chicken melanocortin 2 (ACTH)-receptor gene.

27 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

27 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis

27 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen

27 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JNEUROIM.2010.10.030

27 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21081248 AND SRC:MED&resulttype=core&format=json

16 January 2020

1 reference